The US Food and Drug Administration (FDA) has threatened to take the morning sickness drug Kim Kardashian is promoting off the market because she was disseminating ‘misleading’ information.
The pregnant reality star announced last month on social media that she’s ‘partnering’ with Duchesnay, the manufacturer of anti-morning sickness drug Diclegis, to raise awareness for morning sickness. From the company’s press release however, it looks like Kim is being paid to promote the product to her millions of followers … something that a rep later confirmed to TMZ.
As part of the partnership, Kim put up a promotional post on her Facebook, Instagram and Twitter … but the FDA took issue with Kim’s endorsement because it only contained the benefits of using the drug and not its risks and/or side effects. In a warning letter fired off to Duchesnay, the regulating agency acknowledges that the post had a link pointing to the full risk information about the drug, but it still ‘does not mitigate the misleading omission of risk information.’
FDA labeled Kim’s endorsement ‘misleading,’ and warned Duchesnay to ‘immediately cease misbranding’ the drug or stop selling it. It also suggested that the company correct the problem by getting Kim to repost her endorsement with the proper warnings.
For now, Kim’s endorsement of the drug has been taken down on Facebook and Instagram, but it is still up on Twitter.